Animalcare GroupSTU:WQ7 76 EV-to-Revenue is 2.71 as of Jun. 24, 2026, which is 28% above its 10-year median of 2.12. GuruFocus rates STU:WQ7 with a GF Score™ of 76/100 and a GF Value™ of €2.84 (Fairly Valued). The stock has 7 warning signs investors should review. Among 961 Drug Manufacturers companies, Animalcare Group ranks worse than 55.36% on this metric.
EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Animalcare Group's enterprise value is €279.5 Mil.
Animalcare Group's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was €103.3 Mil. Therefore, Animalcare Group's EV-to-Revenue for today is 2.71.
The historical rank and industry rank for Animalcare Group's EV-to-Revenue or its related term are showing as below:
STU:WQ7'
s EV-to-Revenue Range Over the Past 10 Years
Min: 1.3 Med: 2.12 Max: 6.01
Current: 2.73
During the past 13 years, the highest EV-to-Revenue of Animalcare Group was 6.01. The lowest was 1.30. And the median was 2.12.
STU:WQ7's EV-to-Revenue is ranked worse than 55.36% of 961
companies
in the Drug Manufacturers industry
Industry Median: 2.35
vs STU:WQ7: 2.73
As of today (2026-06-24), Animalcare Group's stock price is €3.00.
Animalcare Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was €1.49. Therefore, Animalcare Group's PS Ratio for today is 2.01.
Animalcare Group (STU:WQ7) EV-to-Revenue Explanation
Animalcare Group's share price for today is €3.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2025 was €1.49.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Animalcare Group EV-to-Revenue Related Terms
Animalcare Group EV-to-Revenue Historical Data
* Premium members only.
The historical data trend for Animalcare Group's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:WQ7 vs ZTS, UTHR, VTRS: EV-to-Revenue Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Animalcare Group's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Animalcare Group EV-to-Revenue vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Animalcare Group's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Animalcare Group's EV-to-Revenue falls into.
Animalcare Group's current Enterprise Value is €279.5 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Animalcare Group's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was €103.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Animalcare Group (STU:WQ7) has a EV-to-Revenue of 2.71 as of Jun. 24, 2026. EV to Revenue ratio is the company's enterprise value divided by sales. View historical data on Animalcare Group and its competitors. This is 28% above median its historical median of 2.12. Over the past decade, Animalcare Group's EV-to-Revenue has ranged from 1.30 to 6.01. According to the industry distribution chart, Animalcare Group ranks #532 out of 961 companies in the Drug Manufacturers industry, placing it in the top 55.4%.
Is Animalcare Group's EV-to-Revenue too high?
Animalcare Group's current EV-to-Revenue of 2.71 is 28% above median its 10-year median of 2.12. Over the past 10 years, this metric has ranged from a low of 1.30 to a high of 6.01. The Drug Manufacturers industry median EV-to-Revenue is 2.35. Animalcare Group's value of 2.71 is 15.3% above this industry median. Based on the distribution chart, Animalcare Group ranks #532 out of 961 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Animalcare Group has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Animalcare Group's EV-to-Revenue compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Animalcare Group ranks #532 out of 961 companies for EV-to-Revenue. This places Animalcare Group in the lower half of its industry. The industry median EV-to-Revenue is 2.35. Animalcare Group's value of 2.71 is 15.3% above this benchmark. Historically, Animalcare Group's own EV-to-Revenue has ranged from 1.30 to 6.01 over the past decade. While the company's 10-year median is 2.12 vs. the industry median of 2.35, Animalcare Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-Revenue for a Drug Manufacturers company?
The median EV-to-Revenue among Drug Manufacturers companies is 2.35, based on 961 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-Revenue significantly above this median, while those in the bottom quartile fall well below. However, EV-to-Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Animalcare Group's current EV-to-Revenue of 2.71 is 15.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-Revenue mean?
A high EV-to-Revenue can signal that a stock is expensive relative to its fundamentals. EV to Revenue ratio is the company's enterprise value divided by sales. View historical data on Animalcare Group and its competitors. For the Drug Manufacturers industry, the median EV-to-Revenue is 2.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Animalcare Group's current EV-to-Revenue is 2.71, which is 28% above median its own 10-year median of 2.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Animalcare Group stock overvalued right now?
Based on GuruFocus' analysis, Animalcare Group (STU:WQ7) is currently considered Fairly Valued. The stock's GF Value™ is €2.84, compared to a current price of €3.00 — trading 5.6% above its estimated fair value. The current EV-to-Revenue is 2.71, which is 28% above median its 10-year median of 2.12 and 15.3% above the Drug Manufacturers industry median of 2.35. Animalcare Group's overall GF Score™ is 76/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-Revenue calculated?
EV-to-Revenue is calculated from a company's financial statements. For Animalcare Group (STU:WQ7), the current EV-to-Revenue is 2.71 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Animalcare Group (STU:WQ7) Overvalued in 2026?
Based on GuruFocus' analysis, Animalcare Group stock appears to be overvalued.
The current stock price of €3.00 is trading 5.6% above its estimated GF Value™ of €2.84.
GuruFocus considers Animalcare Group to be Fairly Valued.
Key valuation signals for STU:WQ7:
EV-to-Revenue: 2.71 (28% above median its 10-year median of 2.12)
GF Value™: €2.84 vs. price of €3.00 (5.6% above fair value)
Industry Position: 15.3% above the Drug Manufacturers median (#532 of 961)
No single metric tells the full story. See the STU:WQ7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Animalcare Group PLC is active in the healthcare division in the United Kingdom. It is a generic veterinary medicines company. The company mainly caters to veterinary professionals in the treatment of companion animals through a product line comprised of licensed veterinary medicines and companion animal identification products and services. The company operates in Animalcare Europe and Randlab segment. The company derives maximum revenue from the Animalcare Europe segment engaged in development and sale of veterinary pharmaceutical products in Europe and the European International Partners network. Geographically, the company derives maximum revenue from Europe region, followed by Asia-Pacific and other regions.
76GF Score
Get the complete analysis for STU:WQ7
EV-to-Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:WQ7 has been successfully added to your 
